Loading
A Singapore study that builds on the earlier safety work with a cooling-and-compression device for the hands and feet, now in 200 patients.
The National University Hospital, Singapore, group that published a safety series of continuous-flow limb cryocompression (13 patients, 142 cycles, no grade 2 or worse neuropathy) is running an expansion study of the Paxman Limb Cryocompression System with an estimated 200 participants. Its earlier studies are NCT03299582 and NCT05095051.
Shares Paxman, Limb cryocompression devices for chemotherapy nerve damage (Paxman Neuropathy System, Hilotherm ChemoCare) and the tag machines-wave3.
Shares Limb cryocompression devices for chemotherapy nerve damage (Paxman Neuropathy System, Hilotherm ChemoCare) and the tag machines-wave3.
Shares Paxman and the tag machines-wave3.
Shares Limb cryocompression devices for chemotherapy nerve damage (Paxman Neuropathy System, Hilotherm ChemoCare) and the tag machines-wave3.
Shares Limb cryocompression devices for chemotherapy nerve damage (Paxman Neuropathy System, Hilotherm ChemoCare) and the tag machines-wave3.
Shares Limb cryocompression devices for chemotherapy nerve damage (Paxman Neuropathy System, Hilotherm ChemoCare) and the tag machines-wave3.
Shares Limb cryocompression devices for chemotherapy nerve damage (Paxman Neuropathy System, Hilotherm ChemoCare) and the tag machines-wave3.
Shares Paxman, Limb cryocompression devices for chemotherapy nerve damage (Paxman Neuropathy System, Hilotherm ChemoCare) and the tag machines-wave3.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/